News

Women in England and Wales had an average of 1.44 children between 2022 and 2023 according to data published by the Office for National Statistics, the lowest rate on record.

A recent phase 3 trial has demonstrated that stereotactic body radiotherapy (SBRT) is a viable treatment for localised prostate cancer…

A major international study has linked rifaximin with the global rise of a multidrug-resistant bacterial pathogen.

The American College of Gastroenterology (ACG) has issued a new clinical guideline to help healthcare providers more effectively manage Helicobacter pylori….

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to improve management of this chronic condition.  

A recent multicenter study led by researchers including Talha Badar and Moazzam Shahzad has highlighted the challenging prognosis of TP53-mutated acute myeloid leukemia.

Prostate cancer remains a significant health concern for men, particularly those aged between 50 and 60 years.

A NEW clinical trial has found that the asthma drug montelukast does not shorten the duration of symptoms for mild-to-moderate COVID-19 patients compared to a placebo.